Human TL1A-DR3 inhibition Kit (TR-FRET)

Customer Reviews
Cat. No. / Size
Price
Qty
FRT-02-100tests
$885.00
FRT-02-500tests
$2960.00
FRT-02-10000tests (500tests X 20)
Inquiry
ETA of in-stock products:2 business days

Product Details

  • FAB

    1. Comprehensive validation - Validated with various antibody drugs.
    2. Simple and fast operation - No complicated washing steps, significantly reducing time.
    3. High batch consistency - Strict control over raw materials and finished product quality, ensuring a stable supply.
    4. Accurate and reliable results - High sensitivity with minimal matrix effects.
    5. High throughput capability - Support multiple product specifications, ideal for high-throughput screening.
    6. Fast completion - Results in just 1 hour.
  • Product Specifications

    Assay Type
    Competition-TR-FRET
    Reactivity
    Human
    Regulatory Status
    RUO
    Assay Time
    1 hr
    Sample volume
    10 μL

  • Product Overview

    The Human TL1A-DR3 inhibition Kit (TR-FRET) is based on a homogeneous (no wash) competition TR-FRET technology (Time-Resolved Fluorescence Resonance Energy Transfer) to screening for inhibitors of human TL1A binding to human DR3 within 0.5-1 hours. It can also be used as a universal detection tool to identify the ability of TL1A to bind to human DR3.

  • Storage

    1. Store the unopened kit at 2-8°C upon receipt.

    2. Locate the expiration date on the outer packaging and do not use reagents beyond their expiration date.

    3. The opened kit should be stored according to the storage conditions listed in the Components Table. The shelf life of the opened kit is 30 days from the date of opening.

  • Materials Provided

    ID
    Components
    Size
    FRT02-C01
    Human TL1A Protein Europium-chelate
    100 tests/500 tests
    FRT02-C02
    FA Labeled Human DR3 Protein
    100 tests/500 tests
    FRT02-C03
    Monoclonal Anti-TL1A Antibody, Human IgG1
    20 μg/100 tests 100 μg/500 tests
    DB-04
    TR-FRET Sample Dilution Buffer, pH7.4
    50 mL/100 tests & 500 tests
    DB-05
    TR-FRET Detection Buffer, pH7.4
    50 mL/100 tests & 500 tests

  • Assay Principles

    This Human TL1A-DR3 inhibition kit (TR-FRET) is based on TR-FRET technology (Time-Resolved Fluorescence Resonance Energy Transfer). Use a mixture of biotinylated human TL1A and Europium-chelate labeled streptavidin as the donor and FA labeled human DR3 protein as the acceptor.

    - In the absence of inhibitors for human TL1A binding to human DR3, the donor and acceptor are in close proximity due to the binding of human TL1A and FA-labeled human DR3. Upon excitation with a specific light source, the donor emits a 620 nm signal, which is absorbed by the acceptor, resulting in a 665 nm emission.

    - In the presence of inhibitors that block the binding of human TL1A to human DR3, the donor-acceptor interaction is disrupted, preventing FRET from occurring.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • Bioactivity-TR-FRET 

    Please refer to DS document for the assay protocol.

     TL1A-DR3 TR-FRET

    In this TR-FRET assay, Human TL1A Protein Europium-chelate is used as the Donor and FA Labeled Human DR3 Protein is used as the Acceptor. An inhibition Assay was performed to evaluate the interaction between human TL1A and human DR3 using Monoclonal Anti-TL1A Antibody, Human IgG1 resulting in a typical IC50 of 3.024 nM (QC tested).

  •  TL1A-DR3 TR-FRET

    The kit is suitable for the detection and characterization of TL1A/DR3 inhibitors. It was shown that the two anti-TL1A antibodies (Afimkibart& Tulisokibart) disrupted the interaction, with an IC50 of 2.890 & 8.198 nM.

Customer Reviews
Writing Reviews

Recent Advances

 
Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland